Arritmias Ventriculares Letais | 19 ABR 20
Interações farmacológicas no QTc no tratamento exploratório COVID-19
Pacientes gravemente doentes geralmente apresentam comorbidades que podem aumentar o risco de arritmias graves.
Autor/a: Dan M. Roden, Robert A. Harrington, Athena Poppas Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
Página 1
- Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila).2006;44:173-175.2.
- Morgan ND, Patel SV, Dvorkina O. Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus. J Clin Rheumatol.2013;19:286-288.3.
- O'Laughlin JP, Mehta PH, Wong BC. Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine. Case Reports in Cardiology.2016;2016:4626279. doi: 10.1155/2016/4626279.4.
- de Olano J, Howland MA, Su MK, Hoffman RS, Biary R. Toxicokinetics of hydroxychloroquine following a massive overdose. AmJ Emerg Med.2019;37:2264.e5-2264.e8.5.
- Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19 [published online ahead of print March 25, 2020]. Mayo Clin Proc.doi: 10.1016/j.mayocp.2020.03.024. https://www.elsevier.com/__data/assets/pdf_file/0004/996745/MCP_Possible-COVID-19-Pharmacotherapies.pdf. Accessed April 2, 2020.6.
- Choi Y, Lim H-S, Chung D, Choi J-G, Yoon D. Risk evaluation of azithromycin-induced QT prolongation in real-world practice. BioMed Research International.2018:1574806.doi: 10.1155/2018/1574806.7.
- Sears SP, Getz TW, Austin CO, Palmer WC, Boyd EA, Stancampiano FF. Incidence of sustained ventricular tachycardia in patients with prolonged QTc after the administration of azithromycin: aretrospective study. Drugs Real World Outcomes.2016;3:99-105.8.
- Huang BH, Wu CH, Hsia CP, Yin Chen C. Azithromycin-induced torsade de pointes. Pacing Clin Electrophysiol.2007;30:1579-1582.9.
- Kezerashvili A, Khattak H, Barsky A, Nazari R, Fisher JD. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors. J Interv Card Electrophysiol.2007;18:243-246.10.
- Ray WA, Murray KT, Hall K, Arbogast PG, St
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024